StreetInsider.com News Articles

Form SCHEDULE 13G/A OptimizeRx Corp Filed by: ROYCE & ASSOCIATES LP

Wed, 21 Oct 2026 12:31:00 -0400

si-local-file:///var/storage/secattach/20261021/27215304.html

Form 4 OptimizeRx Corp For: Oct 01 Filed by: D'Silva Andrew J.

Fri, 02 Oct 2026 10:00:00 -0400

si-local-file:///var/storage/secattach/20261002/27139831.html

OptimizeRX (OPRX) PT Raised to $11 at B.Riley

Tue, 29 Sep 2026 09:07:56 -0400

B.Riley analyst Kyle Bauser raised the price target on OptimizeRX (NASDAQ: OPRX) to $11.00 (from $10.00) while maintaining a Buy rating.

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

Tue, 22 Sep 2026 08:00:00 -0400

Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisers using The Trade Desk

WALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at critical decision points, today announced an integration with OpenPath, The Trade Desk’s supply path optimization solution, making OptimizeRx’s authenticated point of care inventory available directly to advertisers using The Trade Desk’s leading, data-driven demand side platform (DSP).

Through OpenPath, advertisers using

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

Tue, 22 Sep 2026 08:00:00 -0400

Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisers using The Trade Desk

Through OpenPath, advertisers using

OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence

Mon, 14 Sep 2026 08:00:00 -0400

New functionality helps DSPs and agency planners create deterministic HCP and consumer audiences faster, using one single workflow

WALTHAM, Mass., Sept. 14, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at the most important decision points has expanded its patent-pending, AI-powered Natural Language Audience Builder (NLAB) tool to allow media planners and buyers to build both claims-grade HCP audiences and privacy-safe direct-to-consumer (DTC) audiences in the same workflow, from a shared plain-language

OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence

Mon, 14 Sep 2026 08:00:00 -0400

New functionality helps DSPs and agency planners create deterministic HCP and consumer audiences faster, using one single workflow

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

Tue, 08 Sep 2026 07:30:00 -0400

WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced that management will participate in the 10^th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 10, 2026, in New York, NY.

To request a meeting or for more details about the conferences please reach out to your institutional contact.

About OptimizeRx

OptimizeRx is a leading healthcare technology company that’s

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

Tue, 08 Sep 2026 07:30:00 -0400

To request a meeting or for more details about the conferences please reach out to your institutional contact.

About OptimizeRx

OptimizeRx is a leading healthcare technology company that’s

OptimizeRx names former J&J data science officer as company advisor

Wed, 02 Sep 2026 07:30:47 -0400

OptimizeRx Corp. (Nasdaq: OPRX) has appointed Troy Sarich, a former Johnson & Johnson executive, as a company advisor, according to a press release from the Waltham, Massachusetts-based healthcare technology firm.

Sarich previously served as Chief Commercial Data Science Officer at Johnson & Johnson, where he worked on scientific and commercial capabilities for the company's Innovative Medicine business. He brings nearly 30 years of experience in global healthcare, life sciences, and pharmaceutical commercialization, with a focus on data, analytics, and artificial intelligence.

During his career, Sarich held positions in research and development and commercial organizations, with involvement in clinical development and commercialization of

OptimizeRx names former J&J data science officer as company advisor

Wed, 02 Sep 2026 07:30:47 -0400

During his career, Sarich held positions in research and development and commercial organizations, with involvement in clinical development and commercialization of

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

Wed, 02 Sep 2026 07:30:00 -0400

Experienced pharmaceutical and healthcare executive joins advisory board to help accelerate innovation and strengthen life sciences marketing technology

WALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced the appointment of Troy Sarich as a Company advisor. Sarich brings nearly 30 years of extensive experience within global healthcare, life sciences and pharmaceutical commercialization to the advisory board, including deep expertise in data, analytics, and artificial intelligence.

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

Wed, 02 Sep 2026 07:30:00 -0400

Experienced pharmaceutical and healthcare executive joins advisory board to help accelerate innovation and strengthen life sciences marketing technology

Form 4 OptimizeRx Corp For: Aug 20 Filed by: Silvestro Stephen L

Mon, 24 Aug 2026 16:58:00 -0400

si-local-file:///var/storage/secattach/20260824/26968920.html

Form 4 OptimizeRx Corp For: Aug 20 Filed by: Silvestro Stephen L

Mon, 24 Aug 2026 16:58:00 -0400

si-local-file:///var/storage/secattach/20260824/26968920.html

Form 4 OptimizeRx Corp For: Aug 20 Filed by: D'Silva Andrew J.

Mon, 24 Aug 2026 16:58:00 -0400

si-local-file:///var/storage/secattach/20260824/26968917.html

Form 4 OptimizeRx Corp For: Aug 20 Filed by: D'Silva Andrew J.

Mon, 24 Aug 2026 16:58:00 -0400

si-local-file:///var/storage/secattach/20260824/26968917.html

Form 4 OptimizeRx Corp For: Aug 20 Filed by: Merrell Brendan W.

Mon, 24 Aug 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260824/26968912.html

Form 4 OptimizeRx Corp For: Aug 20 Filed by: Merrell Brendan W.

Mon, 24 Aug 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260824/26968912.html

Form 4 OptimizeRx Corp For: Aug 20 Filed by: Odence-Ford Marion

Mon, 24 Aug 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260824/26968911.html

Form 4 OptimizeRx Corp For: Aug 20 Filed by: Odence-Ford Marion

Mon, 24 Aug 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260824/26968911.html

Form 4 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W.

Mon, 24 Aug 2026 15:15:00 -0400

si-local-file:///var/storage/secattach/20260824/26967729.html

Form 4 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W.

Mon, 24 Aug 2026 15:15:00 -0400

si-local-file:///var/storage/secattach/20260824/26967729.html

Form 4 OptimizeRx Corp For: Aug 21 Filed by: Silvestro Stephen L

Mon, 24 Aug 2026 15:15:00 -0400

si-local-file:///var/storage/secattach/20260824/26967723.html

Form 4 OptimizeRx Corp For: Aug 21 Filed by: Silvestro Stephen L

Mon, 24 Aug 2026 15:15:00 -0400

si-local-file:///var/storage/secattach/20260824/26967723.html